Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

Exclusion criteria

• ✕. Active hepatitis B or active hepatitis C
• ✕. Active HTLV infection
• ✕. HIV infection
• ✕. Uncontrolled, active bacterial, viral, or fungal infection.
• ✕. CNS disease that is progressive on therapy, or with CNS parenchymal lesions that might increase the risk of CNS toxicity.
• ✕. Clinically active CNS dysfunction or known history of irreversible central neurological toxicity related to prior antileukemic therapy.
• ✕. Receipt of prior CD7 targeted therapy.
• ✕. Radiation therapy within 2 weeks prior to completion of screening, other than prophylaxis for CNS disease.